Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data
Go back to Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data| (NASDAQ: SNDX) | Delayed: 19.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.32 | 52 Week High | $18.03 | |||
| Open | $19.32 | 52 Week Low | $8.97 | |||
| Day High | $19.32 | P/E | N/A | |||
| Day Low | $19.32 | EPS | $0.00 | |||
| Volume | 100 | |||||

